ENST00000612748.1:c.100A>G

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The ENST00000612748.1(PEG10):​c.100A>G​(p.Arg34Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000019 in 1,371,394 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 7/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

PEG10
ENST00000612748.1 missense

Scores

1
2
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.40

Publications

0 publications found
Variant links:
Genes affected
PEG10 (HGNC:14005): (paternally expressed 10) This is a paternally expressed imprinted gene that is thought to have been derived from the Ty3/Gypsy family of retrotransposons. It contains two overlapping open reading frames, RF1 and RF2, and expresses two proteins: a shorter, gag-like protein (with a CCHC-type zinc finger domain) from RF1; and a longer, gag/pol-like fusion protein (with an additional aspartic protease motif) from RF1/RF2 by -1 translational frameshifting (-1 FS). While -1 FS has been observed in RNA viruses and transposons in both prokaryotes and eukaryotes, this gene represents the first example of -1 FS in a eukaryotic cellular gene. This gene is highly conserved across mammalian species and retains the heptanucleotide (GGGAAAC) and pseudoknot elements required for -1 FS. It is expressed in adult and embryonic tissues (most notably in placenta) and reported to have a role in cell proliferation, differentiation and apoptosis. Overexpression of this gene has been associated with several malignancies, such as hepatocellular carcinoma and B-cell lymphocytic leukemia. Knockout mice lacking this gene showed early embryonic lethality with placental defects, indicating the importance of this gene in embryonic development. Additional isoforms resulting from alternatively spliced transcript variants, and use of upstream non-AUG (CUG) start codon have been reported for this gene. [provided by RefSeq, Oct 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.18176797).
BS2
High AC in GnomAdExome4 at 26 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEG10NM_001172437.2 linkc.100A>G p.Arg34Gly missense_variant Exon 2 of 2 NP_001165908.1 Q86TG7-4
PEG10NM_001172438.3 linkc.100A>G p.Arg34Gly missense_variant Exon 2 of 2 NP_001165909.1 Q86TG7-5
PEG10NM_001184961.1 linkc.-27A>G 5_prime_UTR_variant Exon 2 of 2 NP_001171890.1 Q86TG7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEG10ENST00000612748.1 linkc.100A>G p.Arg34Gly missense_variant Exon 2 of 3 5 ENSP00000480676.1 A0A087WX23

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
133154
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000190
AC:
26
AN:
1371394
Hom.:
0
Cov.:
32
AF XY:
0.0000164
AC XY:
11
AN XY:
672702
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30838
American (AMR)
AF:
0.00
AC:
0
AN:
33686
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23724
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35388
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76100
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45864
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5554
European-Non Finnish (NFE)
AF:
0.0000244
AC:
26
AN:
1063500
Other (OTH)
AF:
0.00
AC:
0
AN:
56740
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 03, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.100A>G (p.R34G) alteration is located in exon 2 (coding exon 2) of the PEG10 gene. This alteration results from a A to G substitution at nucleotide position 100, causing the arginine (R) at amino acid position 34 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.51
CADD
Uncertain
25
DANN
Benign
0.87
DEOGEN2
Benign
0.024
T;.
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.57
T;T
MetaRNN
Benign
0.18
T;T
PhyloP100
3.4
PrimateAI
Uncertain
0.64
T
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.018
B;.
Vest4
0.26
MVP
0.29
GERP RS
3.4
gMVP
0.30
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1193484540; hg19: chr7-94292740; API